Skip to main content

Additional Articles by the Authors

Michael S. Broder, MD, MSHS
Qiufei Ma, PhD
Tingjian Yan, PhD
Jie Zhang, PhD
Eunice Chang, PhD
David Kuzan, MD
Lamis Eldjerou, MD
Business, Original Research
The Cost of Hematopoietic Stem-Cell Transplantation in the United States
Michael S. Broder, MD, MSHS; Tiffany P. Quock, PhD, MS; Eunice Chang, PhD; Sheila R. Reddy, PhD, RPh; Rajni Agarwal-Hashmi, MD; Sally Arai, MD; Kathleen F. Villa, MS
Stakeholder Perspective
More Data Analysis Is Needed to Improve Outcomes, Lower Costs, and Maximize Appropriate Resource Use
James T. Kenney, RPh, MBA
Read More
Business
Economic Burden of Toxicities Associated with Treating Metastatic Melanoma in the United States
Stakeholder Perspective
Reducing Adverse Events and Healthcare Resource Waste by Careful Selection of the Best Drug Therapy
Read More
Business
The Impact of 5-HT3RA Use on Cost and Utilization in Patients with Chemotherapy- Induced Nausea and Vomiting: Systematic Review of the Literature
Stakeholder Perspective
The Value of Pharmaceuticals in the Prevention and Treatment of CINV
Read More
Business
Hematologic Complications, Healthcare Utilization, and Costs in Commercially Insured Patients with Myelodysplastic Syndrome Receiving Supportive Care
Stakeholder Perspective
Reconsidering the Management of Younger Patients with Myelodysplastic Syndrome
Read More

Results 1 - 4 of 4